99% Savings - Buy Just @1 Rs X
Rheoran SF 50 Mcg/500 Mcg Octacap is a prescription medicine that is available as a Capsule. Rheoran SF 50 Mcg/500 Mcg Octacap also has some secondary and off-label uses. These are listed below.
The right dosage of Rheoran SF 50 Mcg/500 Mcg Octacap depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Rheoran SF 50 Mcg/500 Mcg Octacap also has some side effects, the most common being Shortness of Breath, Throat Irritation, Nosebleed. Besides the aforementioned side effects, there are other adverse effects of Rheoran SF 50 Mcg/500 Mcg Octacap as well, which are listed below. These side effects of Rheoran SF 50 Mcg/500 Mcg Octacap are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Rheoran SF 50 Mcg/500 Mcg Octacap is Moderate for pregnant women and Mild for women who are breastfeeding. In addition, Rheoran SF 50 Mcg/500 Mcg Octacap's effects on the liver, heart and kidney are discussed below in the Rheoran SF 50 Mcg/500 Mcg Octacap related warnings section.
The section on Rheoran SF 50 Mcg/500 Mcg Octacap contraindications lists all such conditions.
Additionally, Rheoran SF 50 Mcg/500 Mcg Octacap may also adversely react with other medicines. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Rheoran SF 50 Mcg/500 Mcg Octacap is considered safe while driving, and is addictive.
Rheoran SF 50 Mcg/500 Mcg Octacap is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Rheoran SF 50 Mcg/500 Mcg Octacap safe for pregnant women?
Rheoran SF may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Rheoran SF again without your doctor's advice.
Is the use of Rheoran SF 50 Mcg/500 Mcg Octacap safe during breastfeeding?
Side effects of Rheoran SF on breastfeeding women are very mild.
What is the effect of Rheoran SF 50 Mcg/500 Mcg Octacap on the Kidneys?
Using Rheoran SF does not have any harmful effects on kidneys.
What is the effect of Rheoran SF 50 Mcg/500 Mcg Octacap on the Liver?
The liver can be affected by Rheoran SF. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Rheoran SF only after medical advice.
What is the effect of Rheoran SF 50 Mcg/500 Mcg Octacap on the Heart?
Rheoran SF may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
If you are suffering from any of the following diseases, you should not take Rheoran SF 50 Mcg/500 Mcg Octacap unless your doctor advises you to do so -
Is this Rheoran SF 50 Mcg/500 Mcg Octacap habit forming or addictive?
Rheoran SF 50 Mcg/500 Mcg Octacap does not cause addiction.
Interaction between Food and Rheoran SF 50 Mcg/500 Mcg Octacap
Due to a lack of research, nothing can be said about the consequences of taking Rheoran SF 50 Mcg/500 Mcg Octacap together with food.
Interaction between Alcohol and Rheoran SF 50 Mcg/500 Mcg Octacap
Information about the interaction of Rheoran SF 50 Mcg/500 Mcg Octacap and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Serevent Diskus (salmeterol xinafoate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 223-224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1122-1123
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Flonase (fluticasone propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-359